SCHEMBL30359092

SCHEMBL30359092

COc1ccccc1C(=O)N1CC2CCC(C1)N2

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.58
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
MAPK14 Q16539 1/20 0.54
HCRTR1 O43613 4/20 0.53
HCRTR2 O43614 4/20 0.53
TSHR P16473 1/20 0.52
LMNA P02545 1/20 0.52
HSD11B1 P28845 1/20 0.52
KMT2A Q03164 1/20 0.52
POLB P06746 3/20 0.51
KDM4E B2RXH2 3/20 0.51
GAA P10253 1/20 0.51
MGLL Q99685 1/20 0.51
TYR P14679 1/20 0.50
CCR5 P51681 1/20 0.50
ALDH1A1 P00352 2/20 0.49
DRD3 P35462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30359060 0.84 LMNA (0.50) HTTMAPK14LMNAHSD11B1KMT2A
SCHEMBL30359070 0.81 HTT (0.55) HTTCYP2C9CYP2C19MAPK14HCRTR1
SCHEMBL19766699 0.78 HTT (0.90) HTTCYP2C9CYP2C19MAPK14TSHR
SCHEMBL11714770 0.78 HTT (0.90) HTTCYP2C9CYP2C19MAPK14TSHR
SCHEMBL30359014 0.78 MEN1 (0.52) HTTCYP2C9CYP2C19MAPK14HCRTR1
SCHEMBL17502718 0.77 HTT (0.62) HTTCYP2C9CYP2C19MAPK14HCRTR1
SCHEMBL17502656 0.77 HTT (0.62) HTTCYP2C9CYP2C19MAPK14TSHR
SCHEMBL1671929 0.77 HCRTR1 (0.56) HTTCYP2C9CYP2C19MAPK14HCRTR1
SCHEMBL30359043 0.76 LMNA (0.48) HTTCYP2C9CYP2C19MAPK14HCRTR1
SCHEMBL2540114 0.75 HTT (0.90) HTTCYP2C9CYP2C19MAPK14TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116057057-A Conjugates of alpha 2-adrenoceptor subtype C (alpha-2C) antagonists and TASK1/3 channel blockers for the treatment of sleep apnea 拜耳公司 2023-05-02 CN disclosed